Forskning
June 11, 2012
Factors associated with glomerular hyperfiltration in the early stages of hypertension
P Palatini et al, 2012, Factors associated with glomerular hyperfiltration in the early stages of hypertension, American Journal of Hypertension, published online ahead of print.
ABSTRACT
Glomerular hyperfiltration predicts development of nephropathy in hypertension but the factors responsible for increased glomerular filtration rate (GFR) are not well known. Aim of this study was to examine which clinical variables influence GFR in the early stage of hypertension.
Methods: Participants were 1,106 young-to-middle-age hypertensive adults with creatinine clearance >60 ml/min/1.73 m2. Clinic and ambulatory blood pressures (BPs) were measured and the difference between clinic and 24-h systolic BP was defined as the white-coat effect (WCE). In 606 participants, 24-h urinary epinephrine and norepinephrine were also measured. Glomerular hyperfiltration, defined as a GFR ≥150 ml/min/1.73 m2, was present in 201 subjects.
Results: Patients’ mean age was 33.1 ± 8.5 years and office BP was 146 ± 10.5/94 ± 5.0 mm Hg. In multivariable linear regression, significant predictors of GFR were younger age (P < 0.0001), male gender (P < 0.0001), 24-h systolic BP (P = 0.0001), body mass (P < 0.0001), WCE (P = 0.02), log-epinephrine (P = 0.01), and coffee use (P < 0.01). In a logistic model, independent predictors of glomerular hyperfiltration were obesity (odds ratio, 95% confidence interval = 6.1, 3.8–9.8), male gender (2.9, 1.8–4.9), age <33 years (2.1, 1.5–3.1), ambulatory hypertension (2.0, 1.4–3.0), WCE >15 mm Hg (1.6, 1.1–2.3), heavy coffee use (2.0, 1.1–3.8), and epinephrine >25 mcg/24 h (1.9, 1.2–3.1).
Conclusions: The novel finding of this study is that hyper-reactivity to stress, as determined by urinary epinephrine level and WCE, and coffee use contribute to determining glomerular hyperfiltration in the early stage of hypertension. Our data may help to identify a subset of patients with glomerular hyperfiltration, who may be at increased risk of chronic kidney disease and may benefit from antihypertensive treatment.
